AI Pills in Medical Writing This webinar series, in collaboration with Springer Healthcare Italia, a global leader in healthcare education and communication, is designed to provide radiologists with practical insights into the use of innovative digital tools and technologies to improve the effectiveness of medical writing.

Gadopiclenol receives the JFR 2024 Innovation Award Bracco Imaging is delighted to announce that Gadopiclenol (marketed as Vueway® by Bracco) has been honored with the JFR 2024 Innovation Award in the Jury's Favorite category.

CitraClear signup form - Cloned

Bracco Diagnostics Inc. Achieves 1 Million Injections with VUEWAY® (gadopiclenol) solution for injection Bracco Diagnostics Inc. is proud to announce that its most recently FDA-approved magnetic resonance imaging (MRI) agent, VUEWAY® (gadopiclenol) solution for injection, has reached over one million patient injections at over 480 customer sites.

Bracco Diagnostics and Subtle Medical Announce FDA Clearance of AiMIFY™ Software Bracco Diagnostics Inc. and Subtle Medical, Inc. are thrilled to announce that their collaborative AI-powered software, AiMIFYTM, has received FDA clearance as a Class II software as a medical device (SaMD) for magnetic resonance imaging (MRI) of the brain.

Bracco Diagnostics Inc. Showcases Innovations and More at RSNA 2024 Annual Meeting This year, Bracco’s activities at RSNA are captured by the theme, “Our journey to the future continues today, together”—underscoring Bracco’s commitment to partnering with its customers to advance the practice of radiology.

Bracco triples production of its innovative ultrasound contrast agent in Geneva Over 80 million euros has been invested to build Hexagon, a new manufacturing facility located next to the historical 1996 plant which will, when fully operational, triple the production and distribution of one of the leading products from Bracco's research.

EuSoMII and Bracco together for the 2nd AI Contest One year is gone and we are back in Pisa. It’s the 10th (and 11th) of October 2024, and the EuSoMII, is hosting its annual meeting that brings together people with different backgrounds and expertise from the world of radiology. 

ColoWatch® and Bracco Diagnostics Partner to Expand the Availability of Virtual Colonoscopy for the Early Detection of Colon and Rectal Cancer To learn more, visit Bracco’s booth #3300 at the Radiological Society of North America (RSNA) 2024 Annual Meeting, to be held from December 1-5 in Chicago, Illinois

Webinar: Effective Gadolinium Reduction with the New High- Relaxivity Gadopiclenol in CNS We are pleased to invite you to join an educational webinar entitled Effective Gadolinium Reduction with the New High- Relaxivity Gadopiclenol in CNS scheduled for January 15 from 6:00 to 7:00 pm CET.